163 related articles for article (PubMed ID: 29758064)
1. Risk perception and sex behaviour in pregnancy and breastfeeding in high HIV prevalence settings: Programmatic implications for PrEP delivery.
Joseph Davey D; Farley E; Towriss C; Gomba Y; Bekker LG; Gorbach P; Shoptaw S; Coates T; Myer L
PLoS One; 2018; 13(5):e0197143. PubMed ID: 29758064
[TBL] [Abstract][Full Text] [Related]
2. Sexual risk during pregnancy and postpartum periods among HIV-infected and -uninfected South African women: Implications for primary and secondary HIV prevention interventions.
Joseph Davey D; Farley E; Gomba Y; Coates T; Myer L
PLoS One; 2018; 13(3):e0192982. PubMed ID: 29509759
[TBL] [Abstract][Full Text] [Related]
3. Influences on willingness to use vaginal or oral HIV PrEP during pregnancy and breastfeeding in Africa: the multisite MAMMA study.
van der Straten A; Ryan JH; Reddy K; Etima J; Taulo F; Mutero P; Taylor J; Piper J; Musara P;
J Int AIDS Soc; 2020 Jun; 23(6):e25536. PubMed ID: 32524700
[TBL] [Abstract][Full Text] [Related]
4. Emerging evidence from a systematic review of safety of pre-exposure prophylaxis for pregnant and postpartum women: where are we now and where are we heading?
Joseph Davey DL; Pintye J; Baeten JM; Aldrovandi G; Baggaley R; Bekker LG; Celum C; Chi BH; Coates TJ; Haberer JE; Heffron R; Kinuthia J; Matthews LT; McIntyre J; Moodley D; Mofenson LM; Mugo N; Myer L; Mujugira A; Shoptaw S; Stranix-Chibanda L; John-Stewart G;
J Int AIDS Soc; 2020 Jan; 23(1):e25426. PubMed ID: 31912985
[TBL] [Abstract][Full Text] [Related]
5. Protocol for a longitudinal study to evaluate the use of tenofovir-based PrEP for safer conception and pregnancy among women in South Africa.
Matthews LT; Jaggernath M; Kriel Y; Smith PM; O'Neil K; Haberer JE; Hendrix C; Baeten JM; Ware NC; Wirth K; Psaros C; Bangsberg DR; Smit JA
BMJ Open; 2019 Jul; 9(7):e027227. PubMed ID: 31350241
[TBL] [Abstract][Full Text] [Related]
6. Modelling the potential impact of providing preexposure prophylaxis in pregnant and breastfeeding women in South Africa.
Joseph Davey DL; Bekker LG; Gomba Y; Coates T; Myer L; Johnson LF
AIDS; 2019 Jul; 33(8):1391-1395. PubMed ID: 30950882
[TBL] [Abstract][Full Text] [Related]
7. The landscape for HIV pre-exposure prophylaxis during pregnancy and breastfeeding in Malawi and Zambia: A qualitative study.
Zimba C; Maman S; Rosenberg NE; Mutale W; Mweemba O; Dunda W; Phanga T; Chibwe KF; Matenga T; Freeborn K; Schrubbe L; Vwalika B; Chi BH
PLoS One; 2019; 14(10):e0223487. PubMed ID: 31584987
[TBL] [Abstract][Full Text] [Related]
8. Primary HIV prevention in pregnant and lactating Ugandan women: A randomized trial.
Homsy J; King R; Bannink F; Namukwaya Z; Vittinghof E; Amone A; Ojok F; Rukundo G; Amama S; Etima J; Matovu J; Weissglas F; Ojom L; Atim P; Darbes L; Byamugisha J; Rutherford G; Katabira E; Fowler MG;
PLoS One; 2019; 14(2):e0212119. PubMed ID: 30802277
[TBL] [Abstract][Full Text] [Related]
9. Alignment of adherence and risk for HIV acquisition in a demonstration project of pre-exposure prophylaxis among HIV serodiscordant couples in Kenya and Uganda: a prospective analysis of prevention-effective adherence.
Haberer JE; Kidoguchi L; Heffron R; Mugo N; Bukusi E; Katabira E; Asiimwe S; Thomas KK; Celum C; Baeten JM
J Int AIDS Soc; 2017 Jul; 20(1):21842. PubMed ID: 28741331
[TBL] [Abstract][Full Text] [Related]
10. HIV acquisition in pregnancy: implications for mother-to-child transmission at the population level in sub-Saharan Africa.
Marston M; Risher K; Mahy MI
J Int AIDS Soc; 2021 Sep; 24 Suppl 5(Suppl 5):e25783. PubMed ID: 34546647
[TBL] [Abstract][Full Text] [Related]
11. Evaluating the use of oral pre-exposure prophylaxis among pregnant and postpartum adolescent girls and young women in Cape Town, South Africa.
Khadka N; Gorbach PM; Nyemba DC; Mvududu R; Mashele N; Javanbakht M; Nianogo RA; Aldrovandi GM; Bekker LG; Coates TJ; Myer L; Joseph Davey DL
Front Reprod Health; 2023; 5():1224474. PubMed ID: 37795521
[TBL] [Abstract][Full Text] [Related]
12. HIV-Uninfected Kenyan Adolescent and Young Women Share Perspectives on Using Pre-Exposure Prophylaxis During Pregnancy.
Pintye J; Beima-Sofie KM; Makabong'O PA; Njoroge A; Trinidad SB; Heffron RA; Baeten JM; Celum C; Matemo D; Kinuthia J; Kelley MC; John-Stewart GC
AIDS Patient Care STDS; 2018 Dec; 32(12):538-544. PubMed ID: 30036072
[TBL] [Abstract][Full Text] [Related]
13. Adherence challenges with daily oral pre-exposure prophylaxis during pregnancy and the postpartum period in South African women: a cohort study.
Joseph Davey D; Nyemba DC; Castillo-Mancilla J; Wiesner L; Norman J; Mvududu R; Mashele N; Johnson LF; Bekker LG; Gorbach P; Coates TJ; Myer L
J Int AIDS Soc; 2022 Dec; 25(12):e26044. PubMed ID: 36480171
[TBL] [Abstract][Full Text] [Related]
14. "[Repeat] testing and counseling is one of the key [services] that the government should continue providing": participants' perceptions on extended repeat HIV testing and enhanced counseling (ERHTEC) for primary HIV prevention in pregnant and lactating women in the PRIMAL study, Uganda.
Bannink Mbazzi F; Namukwaya Z; Amone A; Ojok F; Etima J; Byamugisha J; Katabira E; Fowler MG; Homsy J; King R;
BMC Public Health; 2020 May; 20(1):694. PubMed ID: 32414405
[TBL] [Abstract][Full Text] [Related]
15. Perinatal outcomes following maternal pre-exposure prophylaxis (PrEP) use during pregnancy: results from a large PrEP implementation program in Kenya.
Dettinger JC; Kinuthia J; Pintye J; Abuna F; Begnel E; Mugwanya K; Sila J; Lagat H; Baeten JM; John-Stewart G
J Int AIDS Soc; 2019 Sep; 22(9):e25378. PubMed ID: 31498563
[TBL] [Abstract][Full Text] [Related]
16. Safer sex knowledge, behavior, and attitudes of inner-city women.
Hobfoll SE; Jackson AP; Lavin J; Britton PJ; Shepherd JB
Health Psychol; 1993 Nov; 12(6):481-8. PubMed ID: 8293732
[TBL] [Abstract][Full Text] [Related]
17. Pre-exposure prophylaxis uptake and early continuation among pregnant and post-partum women within maternal and child health clinics in Kenya: results from an implementation programme.
Kinuthia J; Pintye J; Abuna F; Mugwanya KK; Lagat H; Onyango D; Begnel E; Dettinger J; Baeten JM; John-Stewart G;
Lancet HIV; 2020 Jan; 7(1):e38-e48. PubMed ID: 31813837
[TBL] [Abstract][Full Text] [Related]
18. "I had Made the Decision, and No One was Going to Stop Me" -Facilitators of PrEP Adherence During Pregnancy and Postpartum in Cape Town, South Africa.
Joseph Davey DL; Knight L; Markt-Maloney J; Tsawe N; Gomba Y; Mashele N; Dovel K; Gorbach P; Bekker LG; Coates TJ; Myer L
AIDS Behav; 2021 Dec; 25(12):3978-3986. PubMed ID: 34085132
[TBL] [Abstract][Full Text] [Related]
19. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
20. Understanding barriers to condom usage among HIV-infected African American women.
Bedimo AL; Bennett M; Kissinger P; Clark RA
J Assoc Nurses AIDS Care; 1998; 9(3):48-58. PubMed ID: 9589420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
